Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment offers software and analytics solutions for revenue cycle management, provider network management, payment accuracy, clinical decision support, value-based payment, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. The Network Solutions segment provides solutions for financial, administrative, and clinical and pharmacy transactions; connected consumer health; intelligent healthcare network; electronic business-to-business and consumer-to-business payments; data; and aggregation and analytics of clinical and financial data. The Technology-Enabled Services segment offers solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration, and healthcare consulting. The company serves commercial insurers, private insurers, BlueCross Blue Shield plans, Medicare/Medicaid plans, provider-sponsored payers, third party administrators, emerging technology and data-driven health plans, and other specialty health benefits insurers, as well as hospitals and health systems, physician practices, dentists, pharmacies, skilled nursing facilities, home health agencies, telehealth providers, senior care facilities, laboratories, and other healthcare providers. Change Healthcare Inc. was incorporated in 2016 and is headquartered in Nashville, Tennessee.
IPO Year: 2019
Exchange: NASDAQ
Website: changehealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/20/2022 | $26.00 → $27.75 | Overweight → Neutral | Piper Sandler |
| 9/20/2022 | $27.75 | Buy → Neutral | Citigroup |
| 9/7/2022 | $27.75 | Hold | Truist |
| 4/1/2022 | $25.75 | Neutral | Credit Suisse |
| 2/4/2022 | $25.75 | Neutral → Buy | Citigroup |
EDEN PRAIRIE, Minn. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Optum, a diversified health services company and part of UnitedHealth Group (NYSE: UNH), and Change Healthcare (NASDAQ: CHNG), a health care technology leader, have agreed to combine. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone. This combination unites two technology and service companies focused on serving health care. Their combined capabilities will more effectively connect and simplify core clinical, administrative and payment processes - resu
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
4 - Change Healthcare Inc. (0001756497) (Issuer)
Piper Sandler downgraded Change Healthcare from Overweight to Neutral and set a new price target of $27.75 from $26.00 previously
Citigroup downgraded Change Healthcare from Buy to Neutral and set a new price target of $27.75
Truist initiated coverage of Change Healthcare with a rating of Hold and set a new price target of $27.75
Credit Suisse resumed coverage of Change Healthcare with a rating of Neutral and set a new price target of $25.75
Citigroup upgraded Change Healthcare from Neutral to Buy and set a new price target of $25.75
JP Morgan resumed coverage of Change Healthcare with a rating of Neutral and set a new price target of $25.75
JPMorgan Chase & Co. downgraded Change Healthcare from Overweight to Neutral
15-12G - Change Healthcare Inc. (0001756497) (Filer)
S-8 POS - Change Healthcare Inc. (0001756497) (Filer)
25-NSE - Change Healthcare Inc. (0001756497) (Subject)
8-K - Change Healthcare Inc. (0001756497) (Filer)
8-K - Change Healthcare Inc. (0001756497) (Filer)
10-Q - Change Healthcare Inc. (0001756497) (Filer)
8-K - Change Healthcare Inc. (0001756497) (Filer)
10-K/A - Change Healthcare Inc. (0001756497) (Filer)
8-K - Change Healthcare Inc. (0001756497) (Filer)
15-12G - Change Healthcare Inc. (0001756497) (Filer)
AM Best has commented that the Credit Ratings (ratings) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) and its insurance subsidiaries remain unchanged following its completed acquisition of Change Healthcare Inc. (Change Healthcare) (Nashville, TN) (NASDAQ:CHNG), a leading health care technology company. The outlooks of these Credit Ratings (ratings) remain stable. The close of this transaction had been delayed following the antitrust suit from the U.S. Department of Justice; however, the U.S. federal judge cleared the way for the transaction to be completed late in September. The close of the transaction was announced on Oct. 3, 2022. The transaction i
Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Compan
Revenue growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $884M, including solutions revenue of $831M; solutions revenue growth of 1.8% driven by increased volume and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the first quarter of fiscal year 2023 ended June 30, 2022. "Our first quarter growth, despite headwinds from lower COVID-related activities and customer attrition related to the extended merger process, demonstrates the underlying momentum in the business," said Neil de Crescenzo, president and chief
Change Healthcare Inc. (NASDAQ:CHNG), a leading healthcare technology company, will release first quarter fiscal 2023 financial and operating results after market close on Wednesday, August 3, 2022. The company will also host a conference call on Thursday, August 4, 2022, at 8:00 am Eastern Time. Due to the previously announced transaction with OptumInsight, the company will not be taking questions during the conference call. Investors and other interested parties are invited to listen to the conference call via the Company's website at https://ir.changehealthcare.com/. The webcast will be available for on-demand listening at the aforementioned URL until August 4, 2023. About Change Healt
Strong revenue and cash flow growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $920M, including record solutions revenue of $859M; solutions revenue growth of 6.8% driven by increased volume, COVID-19 activities and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the fourth quarter and fiscal year ended March 31, 2022. "The fourth quarter performance demonstrates the execution of our growth strategy, delivering on our financial objectives while continuing to make investments to advance our capabilities and supp
Change Healthcare Inc. (NASDAQ:CHNG), a leading healthcare technology company, will release fourth quarter and full year fiscal 2022 financial and operating results after market close on Wednesday, May 25, 2022. The company will also host a conference call on Thursday, May 26, 2022, at 8:00 am Eastern Time. Due to the previously announced transaction with OptumInsight, the company will not be taking questions during the conference call. Investors and other interested parties are invited to listen to the conference call via the Company's website at https://ir.changehealthcare.com/. The webcast will be available for on-demand listening at the aforementioned URL until May 26, 2023. About Cha
Combination will benefit patients, payers and providers by lowering costs and improving experiences Optum, a diversified health services company, and Change Healthcare (NASDAQ:CHNG), a health care technology leader, have agreed to extend their merger agreement to December 31, 2022. In a joint statement, the companies said: "The extended agreement reflects our firm belief in the potential of our combination to improve health care, and in our commitment to contesting the meritless legal challenge to this merger." Change Healthcare and Optum share a vision for achieving a simpler, more intelligent and adaptive health system for patients, payers and providers. The combination of Optum and Ch
Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the third quarter of fiscal year 2022 ended December 31, 2021. "The third quarter results demonstrate the underlying strength and momentum in our business. We continue to execute on our growth strategy and invest to advance our capabilities and support our customers and employees," said Neil de Crescenzo, president and chief executive officer. "We will continue to invest in innovation and optimize our cost structure, enabling us to deliver better experiences and outcomes for everyone in the healthcare system." Fiscal 2022 Third Quarter
Change Healthcare Inc. (NASDAQ:CHNG), a leading healthcare technology company, will release third quarter fiscal 2022 financial and operating results after market close on Wednesday, February 2, 2022. The company will also host a conference call on Thursday, February 3, 2022, at 8:00 am Eastern Time. Due to the previously announced transaction with OptumInsight, the company will not be taking questions during the conference call. Investors and other interested parties are invited to listen to the conference call via the Company's website at https://ir.changehealthcare.com/. The webcast will be available for on-demand listening at the aforementioned URL until February 3, 2023. About Change
Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the second quarter of fiscal year 2022 ended September 30, 2021. "Our results this quarter continue to demonstrate solid execution of our growth strategy and the underlying strength and momentum in our business," said Neil de Crescenzo, president and chief executive officer. "We continue to create value for our payer, provider and consumer customers by delivering innovative and transformative solutions. Along with our customers, we remained focused on lowering cost, enhancing access, and improving outcomes for the benefit of everyone in
AM Best has commented that the Credit Ratings (ratings) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) and its insurance subsidiaries remain unchanged following its completed acquisition of Change Healthcare Inc. (Change Healthcare) (Nashville, TN) (NASDAQ:CHNG), a leading health care technology company. The outlooks of these Credit Ratings (ratings) remain stable. The close of this transaction had been delayed following the antitrust suit from the U.S. Department of Justice; however, the U.S. federal judge cleared the way for the transaction to be completed late in September. The close of the transaction was announced on Oct. 3, 2022. The transaction i
Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Compan
Revenue growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $884M, including solutions revenue of $831M; solutions revenue growth of 1.8% driven by increased volume and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the first quarter of fiscal year 2023 ended June 30, 2022. "Our first quarter growth, despite headwinds from lower COVID-related activities and customer attrition related to the extended merger process, demonstrates the underlying momentum in the business," said Neil de Crescenzo, president and chief
Change Healthcare Inc. (NASDAQ:CHNG), a leading healthcare technology company, will release first quarter fiscal 2023 financial and operating results after market close on Wednesday, August 3, 2022. The company will also host a conference call on Thursday, August 4, 2022, at 8:00 am Eastern Time. Due to the previously announced transaction with OptumInsight, the company will not be taking questions during the conference call. Investors and other interested parties are invited to listen to the conference call via the Company's website at https://ir.changehealthcare.com/. The webcast will be available for on-demand listening at the aforementioned URL until August 4, 2023. About Change Healt
Suite combines Luma Health's Patient Success Platform™ solution with Change Healthcare's revenue cycle management solutions to give patients and providers a cohesive experience that spans the entire healthcare journey Today Change Healthcare (NASDAQ:CHNG) launched Patient Engagement, a suite of solutions that seamlessly connects touchpoints across the patient journey, increasing access and improving communication between patients and providers. Change Healthcare's proven revenue cycle management capabilities and Luma Health's industry-leading solutions enable providers to unify operational, clinical, and financial journeys, creating a more streamlined experience for patients. Patients exp
Strong revenue and cash flow growth driven by continued momentum in core business and investment in expanded capabilities Total revenue of $920M, including record solutions revenue of $859M; solutions revenue growth of 6.8% driven by increased volume, COVID-19 activities and new sales Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare"), a leading healthcare technology company, today reported financial results for the fourth quarter and fiscal year ended March 31, 2022. "The fourth quarter performance demonstrates the execution of our growth strategy, delivering on our financial objectives while continuing to make investments to advance our capabilities and supp
Change Healthcare Inc. (NASDAQ:CHNG), a leading healthcare technology company, will release fourth quarter and full year fiscal 2022 financial and operating results after market close on Wednesday, May 25, 2022. The company will also host a conference call on Thursday, May 26, 2022, at 8:00 am Eastern Time. Due to the previously announced transaction with OptumInsight, the company will not be taking questions during the conference call. Investors and other interested parties are invited to listen to the conference call via the Company's website at https://ir.changehealthcare.com/. The webcast will be available for on-demand listening at the aforementioned URL until May 26, 2023. About Cha
InterQual solutions provide health care providers and health plans nationwide with evidence-based, independently peer-reviewed criteria and workflow enhancements to streamline utilization management Today, Change Healthcare (NASDAQ:CHNG) released InterQual® 2022, the latest edition of the company's flagship clinical decision support solution for the delivery of the latest, evidence-based appropriate care. The release includes new criteria for emergent trends, restructured and interactive criteria to streamline workflows, and artificial intelligence (AI) to drive proactive insights and efficiency. All updates have been rigorously researched and independently peer reviewed, so users can feel
Combination will benefit patients, payers and providers by lowering costs and improving experiences Optum, a diversified health services company, and Change Healthcare (NASDAQ:CHNG), a health care technology leader, have agreed to extend their merger agreement to December 31, 2022. In a joint statement, the companies said: "The extended agreement reflects our firm belief in the potential of our combination to improve health care, and in our commitment to contesting the meritless legal challenge to this merger." Change Healthcare and Optum share a vision for achieving a simpler, more intelligent and adaptive health system for patients, payers and providers. The combination of Optum and Ch
Change Healthcare (NASDAQ:CHNG) issued the following statement regarding the announcement that the DOJ intends to pursue litigation to block the proposed merger between Change Healthcare and UnitedHealth Group: "We are aware and disappointed that the DOJ has filed litigation to prevent Change Healthcare from closing our merger with UHG. As we previously disclosed, UHG extended our merger agreement through April 5, 2022. We will continue our support of UHG in working toward closing the merger as we comply with our obligations under the merger agreement." About Change Healthcare Change Healthcare (NASDAQ:CHNG) is a leading healthcare technology company focused on insights, innovation, and
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13D - Change Healthcare Inc. (0001756497) (Subject)
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13G - Change Healthcare Inc. (0001756497) (Subject)
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13G/A - Change Healthcare Inc. (0001756497) (Subject)
SC 13G - Change Healthcare Inc. (0001756497) (Subject)
Raymond James reiterates a Strong Buy rating on UnitedHealth Group Inc (NYSE:UNH) while raising the price target to $635 from $620 as a U.S. judge gave a green signal for Change Healthcare Inc's (NASDAQ:CHNG) acquisition. The ruling ended a 21-month fight between UnitedHealth and regulators. The analyst John Ransom writes that the deal is expected to close within ten days of the judge's decision, but DOJ is "evaluating next steps," and there is a slight chance of an appeal and further delay. For modeling purposes, the analyst assumes the deal closes October 1. Adding in the CHNG deal, Raymond James is increasing the 2022 EPS estimate by $0.11 to $21.96 and the 2023 EPS estimate by $0
Gainers SOBR Safe, Inc. (NASDAQ:SOBR) shares surged 232.8% to settle at $3.03 on Tuesday following a report suggesting The National Transportation Safety Board is recommending that NHTSA require passive alcohol-detection systems. The company is engaged in developing alcohol-detecting devices to address the automotive alcohol sensing spectrum. Amprius Technologies, Inc. (NYSE:AMPX) shares jumped 86.4% to close at $11.00 on Tuesday. Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) surged 60.6% to settle at $2.2005. NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) gained 42.4% to close at $20.79. Strength may be due to short interest in the stock and social media interest. Virax Biolabs Group
Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Company to
Gainers Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million. Virax Biolabs Group Limited (NASDAQ:VRAX) gained 47.7% to $3.6493 after the company announced the distribution of a Monkeypox Virus Antigen Rapid Test Kits which has been launched in markets accepting the CE mark, such as the European Union. BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares gained 25.8% to $6.92. BYND Cannasoft shares jumped over 32% on Monday after the company announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock. TRxADE HEAL
Citigroup analyst Daniel Grosslight downgrades Change Healthcare (NASDAQ:CHNG) from Buy to Neutral.
Change Healthcare's (NASDAQ:CHNG) short percent of float has fallen 26.36% since its last report. The company recently reported that it has 13.17 million shares sold short, which is 5.81% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.3 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short i
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Tuesday. Here are some big stocks recording gains in today’s session. GigaCloud Technology Inc. (NASDAQ:GCT) jumped 19.8% to $15.90. Amprius Technologies, Inc. (NYSE:AMPX) surged 13.5% to $6.70. Studio City International Holdings Limited (NYSE:MSC) rose 13.5% to $2.3150. AEA-Bridges Impact Corp. (NYSE:IMPX) gained 12.5% to $11.07. Alaunos Therapeutics, Inc. (NASDAQ:TCRT) rose 10% to $2.7301. Melco Resorts & Entertainment Limited (NASDAQ:MLCO) gained 9.7% to $6.39. Innoviz Technologies Ltd. (NASDAQ:INVZ) gained 8.9% to $6.03 after JP Morgan initiated coverage on the stock with an Overweight rating and annou
Upgrades UBS upgraded the previous rating for America Movil SAB de CV (NYSE:AMX) from Neutral to Buy. America Movil earned $0.21 in the second quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $22.65 and a 52-week-low of $16.42. America Movil closed at $16.72 at the end of the last trading period. For Norwegian Cruise Line Holdings Ltd (NYSE:NCLH), Truist Securities upgraded the previous rating of Hold to Buy. In the second quarter, Norwegian Cruise Line showed an EPS of $1.14, compared to $1.93 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.90 and a 52-week-low of $10.31. Norwegian Cruise Line closed at $15.33